Home/Filings/4/0001415889-22-002936
4//SEC Filing

Horn Kinney 4

Accession 0001415889-22-002936

CIK 0001750284other

Filed

Mar 13, 8:00 PM ET

Accepted

Mar 14, 4:45 PM ET

Size

8.5 KB

Accession

0001415889-22-002936

Insider Transaction Report

Form 4
Period: 2022-03-10
Horn Kinney
Chief Business Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2022-03-10$2.06/sh+5,253$10,8427,711 total
  • Sale

    Common Stock

    2022-03-10$4.75/sh5,253$24,9522,458 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2022-03-105,253141,785 total
    Exercise: $2.06Exp: 2030-06-10Common Stock (5,253 underlying)
Footnotes (2)
  • [F1]The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person.
  • [F2]The shares subject to the option vest in a series of 48 successive equal monthly installments measured from June 10, 2020, subject to the Reporting Person's continuous service through each applicable vesting date.

Issuer

Olema Pharmaceuticals, Inc.

CIK 0001750284

Entity typeother

Related Parties

1
  • filerCIK 0001831215

Filing Metadata

Form type
4
Filed
Mar 13, 8:00 PM ET
Accepted
Mar 14, 4:45 PM ET
Size
8.5 KB